TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 2656624

Group type: EXPERIMENTAL
Intervention: Cefmetazole (1 g doses administered intravenously 30-90 min before incision, followed by additional doses at 8 and 16 hours later)
Number of subjects: 51

Group type: COMPARATOR
Intervention: Cefoxitin (2 g doses administered intravenously 30-90 min before incision, followed by additional doses at 6 and 12 hours later)
Number of subjects: 51

Group type: EXPERIMENTAL
Intervention: Cefmetazole
Number of subjects: 51

Group type: COMPARATOR
Intervention: Cefoxitin
Number of subjects: 51
Study: 1130977

Group type: EXPERIMENTAL
Intervention: Effeminacy Rating Scale
Number of subjects: 32
Study: 30406725

Group type: EXPERIMENTAL
Intervention: Regular intermittent epidural injection at L2-3
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Regular intermittent epidural injection at L3-4
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Regular intermittent epidural injection at L4-5
Number of subjects: 90
Study: 28881493

Group type: EXPERIMENTAL
Intervention: Tramadol 200 mg/day
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Tramadol 400 mg/day
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Tramadol (all doses)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24
Study: 25277459

Group type: EXPERIMENTAL
Intervention: APM-containing dentifrice
Number of subjects: 300

Group type: COMPARATOR
Intervention: Control dentifrice
Number of subjects: 300
Study: 24725475

Group type: EXPERIMENTAL
Intervention: PMMA-collagen injections
Number of subjects: 147

Group type: COMPARATOR
Intervention: Saline injections (Control)
Number of subjects: 147
Study: 22467118

Group type: EXPERIMENTAL
Intervention: Real rTMS (n=19)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Sham rTMS (n=11)
Number of subjects: 30
Study: 19201295

Group type: EXPERIMENTAL
Intervention: 1,25(OH)(2)D(3) treatment for 3 weeks
Number of subjects: 23

Group type: COMPARATOR
Intervention: Untreated control group
Number of subjects: 23
Study: 17465090

Group type: EXPERIMENTAL
Intervention: New drugs for the treatment of type 2 diabetes
Number of subjects: 0
Study: 15382007

Group type: EXPERIMENTAL
Intervention: 0.125% bupivacaine with 2 micro g/ml fentanyl
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: 0.125% bupivacaine with 1.5 micro g/ml clonidine
Number of subjects: 45

Group type: COMPARATOR
Intervention: Control group (not explicitly mentioned)
Number of subjects: 45
Study: 11274542

Group type: EXPERIMENTAL
Intervention: Baseline CT scans showing ischemic edema
Number of subjects: 786

Group type: COMPARATOR
Intervention: Patients without early CT findings
Number of subjects: 786

Group type: EXPERIMENTAL
Intervention: Hypoattenuating brain tissue at early CT
Number of subjects: 786
Study: 9536833

Group type: EXPERIMENTAL
Intervention: Erythromycin intravenously for 7 days
Number of subjects: 75

Group type: COMPARATOR
Intervention: No treatment (control group)
Number of subjects: 75
Study: 7878712

Group type: EXPERIMENTAL
Intervention: Virus-inactivated C1-INH concentrates
Number of subjects: 89

Group type: COMPARATOR
Intervention: Non-virus-inactivated C1-INH concentrates
Number of subjects: 89
Study: 2397544

Group type: EXPERIMENTAL
Intervention: Traditional Chinese medical herbs under the principle of Bu‐Shen Yi‐Qi
Number of subjects: 60

Group type: COMPARATOR
Intervention: Routine treatments such as oryzanol, vitamin B1 and B6
Number of subjects: 60
Study: 626430

Group type: EXPERIMENTAL
Intervention: Epidural placement of saline solution
Number of subjects: 43

Group type: EXPERIMENTAL
Intervention: Epidural blood placement
Number of subjects: 43
Study: 31843623

Group type: EXPERIMENTAL
Intervention: Photodynamic diagnosis (PDD) using hexaminolevulinate instilled in the bladder before flexible cystoscopy with PDD video cystoscope
Number of subjects: 699

Group type: COMPARATOR
Intervention: White light flexible cystoscope (control group)
Number of subjects: 699

Group type: EXPERIMENTAL
Intervention: Photodynamic diagnosis (PDD)
Number of subjects: 699
Study: 30054173

Group type: EXPERIMENTAL
Intervention: Therapist-led VR exposure therapy followed by a four-week internet-administered VR to in-vivo transition program
Number of subjects: 50

Group type: COMPARATOR
Intervention: Self-led VR exposure therapy followed by the same transition program (after waiting-list)
Number of subjects: 50
Study: 28965004

Group type: EXPERIMENTAL
Intervention: Video-communication intervention
Number of subjects: 227

Group type: EXPERIMENTAL
Intervention: Social support decline during the first year
Number of subjects: 227
Study: 25540170

Group type: EXPERIMENTAL
Intervention: Home-based exercise (n = 11)
Number of subjects: 37

Group type: EXPERIMENTAL
Intervention: Education (n = 9)
Number of subjects: 37

Group type: EXPERIMENTAL
Intervention: Combined exercise and education (n = 8)
Number of subjects: 37

Group type: COMPARATOR
Intervention: Wait-list control (n = 9)
Number of subjects: 37
Study: 24575933

Group type: EXPERIMENTAL
Intervention: Low Birth Weight (LBW)
Number of subjects: 1927

Group type: EXPERIMENTAL
Intervention: Small-for-Gestational Age (SGA)
Number of subjects: 1927

Group type: EXPERIMENTAL
Intervention: Preterm Birth
Number of subjects: 1927

Group type: COMPARATOR
Intervention: Birth Asphyxia
Number of subjects: 1927

Group type: COMPARATOR
Intervention: Sepsis Symptoms
Number of subjects: 1927
Study: 23095369

Group type: EXPERIMENTAL
Intervention: r-hFSH/r-hLH (150 IU r-hFSH/75 IU r-hLH daily for a maximum of 16 days)
Number of subjects: 35

Group type: COMPARATOR
Intervention: hMG-HP (150 IU hMG-HP daily for a maximum of 16 days)
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: r-hFSH/r-hLH
Number of subjects: 35

Group type: COMPARATOR
Intervention: hMG-HP
Number of subjects: 35
Study: 19095687

Group type: EXPERIMENTAL
Intervention: PVT/VF
Number of subjects: 160

Group type: EXPERIMENTAL
Intervention: SMVT
Number of subjects: 160

Group type: COMPARATOR
Intervention: Non-inducible group
Number of subjects: 160
Study: 17374817

Group type: EXPERIMENTAL
Intervention: Drug intervention trials
Number of subjects: 283

Group type: EXPERIMENTAL
Intervention: Multicenter trials
Number of subjects: 283

Group type: EXPERIMENTAL
Intervention: Industry-sponsored trials
Number of subjects: 283

Group type: EXPERIMENTAL
Intervention: Concomitant medication use and comorbidities
Number of subjects: 283
Study: 15196518

Group type: EXPERIMENTAL
Intervention: Perceptual learning training group
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 30
Study: 12014814

Group type: EXPERIMENTAL
Intervention: Buprenorphine with brief counseling
Number of subjects: 14
Study: 9827853

Group type: EXPERIMENTAL
Intervention: Low glycaemic index diet
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: High fibre diet
Number of subjects: 9

Group type: COMPARATOR
Intervention: Control diet
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: High GI diet
Number of subjects: 9
Study: 7570842

Group type: EXPERIMENTAL
Intervention: melarsoprol treatment
Number of subjects: 1083
Study: 1816730

Group type: EXPERIMENTAL
Intervention: Acupuncture
Number of subjects: 44

Group type: COMPARATOR
Intervention: Placebo-diazepam
Number of subjects: 44

Group type: COMPARATOR
Intervention: Diazepam
Number of subjects: 44

Group type: COMPARATOR
Intervention: Sham-acupuncture
Number of subjects: 44
Study: 78529

Group type: EXPERIMENTAL
Intervention: Flutamide 1.5 gm daily
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Flutamide 0.75 gm daily
Number of subjects: 20

Group type: COMPARATOR
Intervention: Flutamide 1.0 mg diethylstilbestrol daily
Number of subjects: 20
Study: 30222494

Group type: EXPERIMENTAL
Intervention: Corrective exercise program
Number of subjects: 65

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 65
Study: 28221053

Group type: EXPERIMENTAL
Intervention: Integrated support model that included antecedent social influence and planning combined with follow‐up performance feedback
Number of subjects: 39

Group type: COMPARATOR
Intervention: Weekly structured follow‐up interviews
Number of subjects: 39
Study: 26082889

Group type: EXPERIMENTAL
Intervention: Auditory-verbal training (20 daily 1-hour sessions over 4 weeks)
Number of subjects: 57

Group type: EXPERIMENTAL
Intervention: Facial affect discrimination training (20 daily 1-hour sessions over 4 weeks)
Number of subjects: 57

Group type: COMPARATOR
Intervention: Treatment as usual (TAU, 4 weeks)
Number of subjects: 57
Study: 23787550

Group type: EXPERIMENTAL
Intervention: Calcium acetate/magnesium carbonate (CaMg)
Number of subjects: 204

Group type: COMPARATOR
Intervention: Sevelamer‐hydrochloride (HCl)
Number of subjects: 204
Study: 21596243

Group type: EXPERIMENTAL
Intervention: Simultaneous bilateral cataract surgery
Number of subjects: 520

Group type: COMPARATOR
Intervention: Sequential bilateral cataract surgery
Number of subjects: 520
Study: 18603317

Group type: EXPERIMENTAL
Intervention: NT-proBNP measurement
Number of subjects: 401
Study: 16886927

Group type: EXPERIMENTAL
Intervention: Ergotamine tartrate
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Acetylsalicylic acid
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40

Group type: COMPARATOR
Intervention: Sumatriptan
Number of subjects: 40

Group type: COMPARATOR
Intervention: Zolmitriptan
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Erythrocyte aggregation
Number of subjects: 40
Study: 16821454

Group type: EXPERIMENTAL
Intervention: Double-blind food challenge with cow's milk
Number of subjects: 43

Group type: COMPARATOR
Intervention: Placebo challenge
Number of subjects: 43

Group type: EXPERIMENTAL
Intervention: Reintroduction of cow's milk
Number of subjects: 43
Study: 12705315

Group type: EXPERIMENTAL
Intervention: Antimicrobial soap (0.2% triclosan)
Number of subjects: 238

Group type: EXPERIMENTAL
Intervention: Plain soap
Number of subjects: 238
Study: 10547086

Group type: EXPERIMENTAL
Intervention: Nicotine gum chewing
Number of subjects: 17

Group type: COMPARATOR
Intervention: Control (baseline measurements)
Number of subjects: 17
Study: 8914461

Group type: EXPERIMENTAL
Intervention: Low-dose cytarabine
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: Low-dose etoposide
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: Combination low-dose therapy (cytarabine and etoposide)
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: Responders (CR + PR cases)
Number of subjects: 54
Study: 1677282

Group type: EXPERIMENTAL
Intervention: Amoxicillin-clavulanate
Number of subjects: 102

Group type: COMPARATOR
Intervention: Gentamicin plus clindamycin
Number of subjects: 102
Study: 6881407

Group type: EXPERIMENTAL
Intervention: Observation of carbon monoxide level in alveolar air
Number of subjects: 170
Study: 29932294

Group type: EXPERIMENTAL
Intervention: nab-paclitaxel plus gemcitabine
Number of subjects: 120

Group type: COMPARATOR
Intervention: gemcitabine alone
Number of subjects: 120
Study: 29317896

Group type: EXPERIMENTAL
Intervention: Peony-Glycyrrhiza Decoction (PGD)
Number of subjects: 41

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 41
Study: 25282555

Group type: EXPERIMENTAL
Intervention: Availability of prior ECGs
Number of subjects: 130
Study: 23590265

Group type: EXPERIMENTAL
Intervention: Ivacaftor (150 mg orally every 12 hours for 48 weeks)
Number of subjects: 52

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 52
Study: 21149654

Group type: EXPERIMENTAL
Intervention: Pentostatin 1.0 mg/m²
Number of subjects: 147

Group type: EXPERIMENTAL
Intervention: Pentostatin 1.5 mg/m²
Number of subjects: 147

Group type: COMPARATOR
Intervention: Control (no pentostatin)
Number of subjects: 147
Study: 18348888

Group type: EXPERIMENTAL
Intervention: Duloxetine treatment
Number of subjects: 668
Study: 16951831

Group type: EXPERIMENTAL
Intervention: Maximal workload prediction models based on age and body mass
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Cross-validation of proposed equations
Number of subjects: 60
Study: 15449635

Group type: EXPERIMENTAL
Intervention: Vaccinated
Number of subjects: 759

Group type: COMPARATOR
Intervention: Nonvaccinated
Number of subjects: 759
Study: 10866914

Group type: EXPERIMENTAL
Intervention: Desflurane anesthesia
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Sevoflurane anesthesia
Number of subjects: 30
Study: 9465239

Group type: EXPERIMENTAL
Intervention: Ultrasound (US) measurement of visceral/subcutaneous adipose thickness
Number of subjects: 30

Group type: COMPARATOR
Intervention: Computed Tomography (CT) measurement of visceral/subcutaneous adipose thickness
Number of subjects: 30

Group type: COMPARATOR
Intervention: Waist-Hip Ratio (W/H)
Number of subjects: 30
Study: 7870930

Group type: EXPERIMENTAL
Intervention: remoxipride 100 mg
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: remoxipride 100 mg plus biperiden 4 mg
Number of subjects: 12

Group type: COMPARATOR
Intervention: biperiden 4 mg
Number of subjects: 12
Study: 2876573

Group type: EXPERIMENTAL
Intervention: 200 mg celiprolol
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: 200 mg celiprolol plus 12.5 mg chlorthalidone
Number of subjects: 22
Study: 28865237

Group type: EXPERIMENTAL
Intervention: LY3031207 (225 mg)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: LY3031207 (25 mg, 75 mg, 275 mg)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: LY3031207
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0

Group type: COMPARATOR
Intervention: Celecoxib (400 mg)
Number of subjects: 0
Study: 27046312

Group type: EXPERIMENTAL
Intervention: Topiramate (50-200 mg per day for 12 weeks)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study: 24998293

Group type: EXPERIMENTAL
Intervention: Isometric resistance training (Arm A)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Passive physical therapy (Control Group)
Number of subjects: 60
Study: 21741107

Group type: EXPERIMENTAL
Intervention: HbA1c≥5.7% and/or FPG≥5.6mmol/l
Number of subjects: 14726

Group type: EXPERIMENTAL
Intervention: HbA1c change-points
Number of subjects: 14726

Group type: EXPERIMENTAL
Intervention: FPG change-points
Number of subjects: 14726

Group type: EXPERIMENTAL
Intervention: Diabetes incidence
Number of subjects: 14726
Study: 20731836

Group type: EXPERIMENTAL
Intervention: Interdisciplinary primary care intervention
Number of subjects: 360

Group type: COMPARATOR
Intervention: Control group (standard care)
Number of subjects: 360
Study: 19010047

Group type: EXPERIMENTAL
Intervention: Human Patient Simulator (HPS) method
Number of subjects: 0

Group type: COMPARATOR
Intervention: Traditional classroom lecture
Number of subjects: 0
Study: 16161395

Group type: EXPERIMENTAL
Intervention: MTA
Number of subjects: 120

Group type: COMPARATOR
Intervention: FC
Number of subjects: 120
Study: 12629661

Group type: EXPERIMENTAL
Intervention: Immunosuppressants after kidney transplantation
Number of subjects: 3

Group type: COMPARATOR
Intervention: Extreme training causing immunosuppression
Number of subjects: 3

Group type: EXPERIMENTAL
Intervention: Interferon treatment for hepatitis C virus
Number of subjects: 3
Study: 10636496

Group type: COMPARATOR
Intervention: Calcium supplementation
Number of subjects: 4589
Study: 8880059

Group type: EXPERIMENTAL
Intervention: Ranitidine 300 mg
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 1677061

Group type: EXPERIMENTAL
Intervention: Atenolol (T)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Atenolol (D)
Number of subjects: 8
Study: 6362125

Group type: EXPERIMENTAL
Intervention: Albendazole (single 400 mg oral dose)
Number of subjects: 870

Group type: EXPERIMENTAL
Intervention: Albendazole (three consecutive days at the same daily dose level)
Number of subjects: 870

Group type: EXPERIMENTAL
Intervention: Albendazole
Number of subjects: 870

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 870
Study: 31776344

Group type: EXPERIMENTAL
Intervention: Mediterranean Diet (MD) adherence intervention
Number of subjects: 566

Group type: COMPARATOR
Intervention: Advice to quit smoking
Number of subjects: 566
Study: 29727302

Group type: EXPERIMENTAL
Intervention: Hospital Clown (HC) present
Number of subjects: 116

Group type: COMPARATOR
Intervention: Standard Care (Control)
Number of subjects: 116
Study: 26285180

Group type: EXPERIMENTAL
Intervention: Progressive explosive-type resistance training (RT) twice a week for 10 weeks; four exercises (hip/thigh) performed in three series each (8-12 repetition maximum)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Care as usual (Control group)
Number of subjects: 80
Study: 24992750

Group type: EXPERIMENTAL
Intervention: Acupuncture for 4 weeks
Number of subjects: 240

Group type: COMPARATOR
Intervention: Cetirizine hydrochloride for 4 weeks
Number of subjects: 240
Study: 22622452

Group type: EXPERIMENTAL
Intervention: Online pre-dilution HF (36 patients)
Number of subjects: 146

Group type: EXPERIMENTAL
Intervention: Online pre-dilution HDF (40 patients)
Number of subjects: 146

Group type: COMPARATOR
Intervention: Low-flux HD (70 patients)
Number of subjects: 146
Study: 20649061

Group type: EXPERIMENTAL
Intervention: ULTRACET
Number of subjects: 180

Group type: COMPARATOR
Intervention: tramadol and acetaminophen
Number of subjects: 180
Study: 18515581

Group type: EXPERIMENTAL
Intervention: off-flap epi-LASIK
Number of subjects: 31

Group type: COMPARATOR
Intervention: on-flap epi-LASIK
Number of subjects: 31
Study: 16579401

Group type: EXPERIMENTAL
Intervention: Sahaj Yoga combined with conventional anti-depressants
Number of subjects: 30

Group type: COMPARATOR
Intervention: Conventional anti-depressants only
Number of subjects: 30
Study: 12028823

Group type: EXPERIMENTAL
Intervention: AD7C‐NTP competitive ELISA test in urine samples from patients with AD
Number of subjects: 3

Group type: EXPERIMENTAL
Intervention: AD7C‐NTP competitive ELISA test in urine samples from early-AD cases
Number of subjects: 3

Group type: EXPERIMENTAL
Intervention: Overall AD cases
Number of subjects: 3

Group type: COMPARATOR
Intervention: Overall controls
Number of subjects: 3
Study: 10779814

Group type: EXPERIMENTAL
Intervention: 20 microg/kg oral granisetron solution
Number of subjects: 294

Group type: EXPERIMENTAL
Intervention: 40 microg/kg oral granisetron solution
Number of subjects: 294

Group type: EXPERIMENTAL
Intervention: Both doses of granisetron (20 microg/kg and 40 microg/kg)
Number of subjects: 294
Study: 8773915

Group type: EXPERIMENTAL
Intervention: Amino acid infusion (primed continuous infusion from t = 1 h to t = 5 h)
Number of subjects: 21

Group type: COMPARATOR
Intervention: No amino acid infusion (control group)
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Amino acid infusion
Number of subjects: 21
Study: 1475222

Group type: EXPERIMENTAL
Intervention: Partial area method for evaluation of equivalency in the rate of absorption of immediate release formulations.
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Confidence interval approach for bioequivalence determinations applied to relevant absorption parameters.
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Cutoff time or point for partial AUC calculation.
Number of subjects: 0
Study: 6560420

Group type: EXPERIMENTAL
Intervention: videotaped modeling
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: videotaped information
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: videotaped information and modeling combined
Number of subjects: 60

Group type: COMPARATOR
Intervention: control (irrelevant) videotape
Number of subjects: 60
Study: 29785102

Group type: EXPERIMENTAL
Intervention: Health coaching self-management program
Number of subjects: 20
Study: 27283622

Group type: EXPERIMENTAL
Intervention: Jaboticaba peel consumption
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 23656430

Group type: EXPERIMENTAL
Intervention: Discourse recounts
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Cognitive measures for older adults
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Cognitive measures for younger adults
Number of subjects: 80
Study: 22658265

Group type: EXPERIMENTAL
Intervention: Two titanium miniplates with Erich's arch bar for 6 weeks
Number of subjects: 3

Group type: EXPERIMENTAL
Intervention: Two titanium miniplates without Erich's arch bar
Number of subjects: 3

Group type: COMPARATOR
Intervention: One titanium miniplate with Erich's arch bar for 6 weeks
Number of subjects: 3
Study: 20167702

Group type: EXPERIMENTAL
Intervention: Avosentan 25 mg/d
Number of subjects: 1392

Group type: EXPERIMENTAL
Intervention: Avosentan 50 mg/d
Number of subjects: 1392

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1392

Group type: EXPERIMENTAL
Intervention: Avosentan
Number of subjects: 1392
Study: 18822975

Group type: EXPERIMENTAL
Intervention: Acupoint electrogymnastics (AE)
Number of subjects: 153

Group type: COMPARATOR
Intervention: Traditional electroacupuncture (TEA)
Number of subjects: 153
Study: 15956269

Group type: EXPERIMENTAL
Intervention: Naltrexone 50 mg/day combined with sertraline 100 mg/day and psychosocial support
Number of subjects: 74

Group type: COMPARATOR
Intervention: Placebo combined with sertraline 100 mg/day and psychosocial support
Number of subjects: 74
Study: 11931398

Group type: EXPERIMENTAL
Intervention: Once-weekly 600 mg rifapentine + 15 mg/kg isoniazid (HRp1)
Number of subjects: 672

Group type: EXPERIMENTAL
Intervention: HRp1 given in 2 of every 3 weeks (HRp1.2/3)
Number of subjects: 672

Group type: COMPARATOR
Intervention: Thrice-weekly isoniazid + rifampicin (HR3)
Number of subjects: 672
Study: 11984133

Group type: EXPERIMENTAL
Intervention: Calcium and antioxidants intervention
Number of subjects: 116

Group type: COMPARATOR
Intervention: Control group (age- and sex-matched, free of polyps)
Number of subjects: 116
Study: 9815520

Group type: EXPERIMENTAL
Intervention: Clodronate 1,600 mg orally per day for 2 years
Number of subjects: 1400

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 1400
Study: 7655833

Group type: EXPERIMENTAL
Intervention: ICE regimen (cisplatin: 20 mg/m2 x day x 5, ifosfamide: 1.8 g/m2 x day x 5, mesna: 1.2 g/m2 x day x 5, etoposide: 100 mg/m2 x day x 5)
Number of subjects: 74

Group type: COMPARATOR
Intervention: CE regimen (cisplatin: 20 mg/m2 x day x 5, etoposide: 100 mg/m2 x day x 5)
Number of subjects: 74
Study: 2462343

Group type: EXPERIMENTAL
Intervention: Encainide administered twice daily (group A)
Number of subjects: 101

Group type: EXPERIMENTAL
Intervention: Encainide administered three times daily (group B)
Number of subjects: 101
Study: 402203

Group type: EXPERIMENTAL
Intervention: Postoperative irradiation to the peripheral lymphatics and/or chest wall
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Radiation plus simple mastectomy
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Radiation to the peripheral lymphatics and/or chest wall
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Treatment of local recurrence
Number of subjects: 0
Study: 6813017

Group type: EXPERIMENTAL
Intervention: Medroxyprogesterone acetate (MPA)
Number of subjects: 6

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 6
Study: 31412879

Group type: EXPERIMENTAL
Intervention: Oral Lactobacillus casei Shirota (LcS) daily for 3 months
Number of subjects: 264

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 264